Holen Sie sich die Stockscreener-App
34.36
2.28%
-0.916
Schlusskurs vom Vortag:
$35.28
Offen:
$35.64
24-Stunden-Volumen:
46,410
Relative Volume:
0.20
Marktkapitalisierung:
$699.90M
Einnahmen:
$71.10M
Nettoeinkommen (Verlust:
$-6.38M
KGV:
-28.62
EPS:
-1.2009
Netto-Cashflow:
$-39.84M
1W Leistung:
-6.11%
1M Leistung:
+29.22%
6M Leistung:
+18.35%
1J Leistung:
+48.92%
1-Tages-Spanne:
$34.36
$35.92
1-Wochen-Bereich:
$34.48
$36.80
52-Wochen-Spanne:
$20.23
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
34.38 | 718.32M | 71.10M | -6.38M | -39.84M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
523.00 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
800.20 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,000.04 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.94 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.37 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Why is Assembly Biosciences stock surging today? By Investing.com - Investing.com Australia
Why is Assembly Biosciences stock surging today? - Investing.com
Assembly Biosciences (ASMB) Shares U.S. Development Costs and Profits with Gilead on Herpes Treatment - GuruFocus
Assembly Bio stock gains after exercising Gilead profit option By Investing.com - Investing.com South Africa
Assembly Bio stock gains after exercising Gilead profit option - Investing.com
Assembly Bio opts into 40% U.S. profit share for herpes drug - Investing.com Canada
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - The Manila Times
Assembly Bio opts into 40% U.S. profit share for herpes drug By Investing.com - Investing.com India
Assembly Biosciences exercises profit share option with Gilead for HSV program - TipRanks
A $75 million Gilead payment is due in Q4, while Assembly Bio expects cash to fund operations into 2029. - Stock Titan
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services - Yahoo Finance
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High? - Yahoo Finance
Should You Buy Assembly Biosciences (ASMB) After Golden Cross? - Yahoo Finance
How Assembly Biosciences Inc. (ASMB) Affects Rotational Strategy Timing - Stock Traders Daily
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
ASMB Maintained by Mizuho -- Price Target Lowered to $45 - GuruFocus
ASMB Initiates Coverage On UBS -- Price Target Announced at $52. - GuruFocus
Assembly Biosciences Price Target Announced at $52.00/Share by UBS - Moomoo
Assembly Biosciences price target raised to $53 from $45 at Mizuho - TipRanks
UBS initiates Assembly Biosciences stock with buy rating on antiviral platform - Investing.com Nigeria
Mizuho lowers Assembly Biosciences stock price target to $45 - Investing.com
Assembly Biosciences Inc (ASMB) Stock Price, Quote, News & History - Benzinga
Price to earnings forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Certain Stock Options of Assembly Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 21-AUG-2026. - marketscreener.com
Wall Street Analysts Think Assembly Biosciences (ASMB) Could Surge 40.66%: Read This Before Placing a Bet - Zacks Investment Research
Q3 EPS Forecast for Assembly Biosciences Raised by Analyst - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Shares Gap UpShould You Buy? - MarketBeat
HC Wainwright Issues Negative Estimate for ASMB Earnings - MarketBeat
Assembly Biosciences (ASMB) Slides 8.92% to $30.01 as Key Support Comes into FocusFundamental Weighted - vinanet.vn
Assembly Biosciences (NASDAQ:ASMB) Earns "Buy" Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Assembly Biosciences stock rating at buy - Investing.com
H.C. Wainwright reiterates Assembly Biosciences stock rating at buy By Investing.com - Investing.com India
ASMB Reiterated by HC Wainwright & Co. -- Maintains Price Target at $50 - GuruFocus
Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TipRanks
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal - Seeking Alpha
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Assembly Biosciences (ASMB) sees Paradigm BioCapital report 7.8% ownership stake - Stock Titan
Why (ASMB) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Trading Up 8.2% on Strong Earnings - MarketBeat
Assembly Biosciences, Inc.: Revenue and Earnings Analysts Forecasts Revisions | ASMB | US0453962070 - marketscreener.com
Assembly Biosciences earnings beat by $0.53, revenue topped estimates - Investing.com Nigeria
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Assembly Biosciences (NASDAQ:ASMB) Issues Quarterly Earnings Results, Beats Expectations By $0.52 EPS - MarketBeat
Assembly Biosciences (ASMB) boosts cash to $320M and narrows loss - Stock Titan
Assembly Biosciences: Q2 Earnings Snapshot - AOL.com
Assembly Biosciences: Cash Runway Projected Into 2029 >ASMB - Moomoo
Assembly Biosciences Projects Operations Funded Into 2029 With $75M Gilead Payment Due - Stock Titan
Assembly Biosciences (ASMB) Surges 9.6% to $29.65 as Biotech Buying Pressure IntensifiesGEX Level - vinanet.vn
Assembly Biosciences (ASMB): Janus Henderson Group discloses 1,359,514-share, 6.9% beneficial stake - Stock Titan
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):